Comparison of Next-Generation Sequencing Panels and Platforms for Detection and Verification of Somatic Tumor Variants for Clinical Diagnostics

Use of next-generation sequencing to detect somatic variants in DNA extracted from formalin-fixed, paraffin-embedded tumor tissues poses a challenge for clinical molecular diagnostic laboratories because of variable DNA quality and quantity, and the potential to detect low allele frequency somatic variants difficult to verify by non –next-generation sequencing methods. We evaluated somatic variant detection performance of the MiSeq and Ion Proton benchtop sequencers using two commercially available panels, the TruSeq Amplicon Cancer Panel and the AmpliSeq Cancer Hotspot Panel Version 2.

Source: Journal of Molecular Diagnostics - October 19, 2016 Category: Pathology Authors: Maksym Misyura, Tong Zhang, Mahadeo A. Sukhai, Mariam Thomas, Swati Garg, Suzanne Kamel-Reid, Tracy L. Stockley Tags: Regular article Source Type: research